Clinical Trial Update: Study of SMT-NK Inj. Plus Pembrolizumab vs Pembrolizumab Monotherapy in Patients With Advanced Biliary Tract Cancer [Phase 2, Phase 3]

View source ↗

Summary

A study comparing SMT-NK Inj. plus pembrolizumab versus pembrolizumab alone in advanced biliary tract cancer is currently recruiting (Phase 2/3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• SMT-NK Inj.

Snippet

Sponsor: SMT bio Co., Ltd. | Conditions: Biliary Tract Cancer | Phase 2, Phase 3 | Status: RECRUITING